Skip to main content
. 2000 Feb 21;191(4):613–624. doi: 10.1084/jem.191.4.613

Figure 3.

Figure 3

DCs process residual 14028 and CS022 expressing Crl-OVA for OVA peptide presentation on MHC-I and MHC-II equally well. Logarithmically growing (OD600 = 1.3–1.5) 14028r Crl-OVA or CS022r Crl-OVA bacteria were treated with 100 μg/ml of gentamycin (a and b), heat killed (HK) at 65°C (c and d), or were left untreated (e and f) before coincubation with DCs for 90 min. After several washes, OVA(257–264)/Kb (a, c, and e) and OVA(265–277)/I-Ab (b, d, and f) were quantitated using CD8OVA and OT4H.2D5 T hybridoma cells, respectively. The results are representative of three independent experiments.